Associated Papers
Accurate affinity models for SH2 domains from peptide binding assays and free-energy regression.
Gagoski D et al.
Protein Science : a Publication of the Protein Society, 2025
Accurate sequence-to-affinity models for SH2 domains from multi-round peptide binding assays coupled with free-energy regression.
Gagoski D et al.
Biorxiv : the Preprint Server for Biology, 2025
Low CCR5 expression protects HIV-specific CD4+ T cells of elite controllers from viral entry.
Claireaux M et al.
Nature Communications, 2022
Lysine acetylation regulates the interaction between proteins and membranes.
Okada AK et al.
Nature Communications, 2021
Rare genetic variability in human drug target genes modulates drug response and can guide precision medicine.
Zhou Y et al.
Science Advances, 2021
Reproducible Analysis of Post-Translational Modifications in Proteomes--Application to Human Mutations.
Holehouse AS et al.
Plos One, 2015
Mutations in C-C chemokine receptor type 5 (CCR5) in South African individuals.
Barmania F et al.
International Journal of Infectious Diseases : Ijid : Official Publication of the International Society for Infectious Diseases, 2013
Genetic variation within the gene encoding the HIV-1 CCR5 coreceptor in two South African populations.
Picton AC et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases, 2010
Analysis of the CCR5 gene coding region diversity in five South American populations reveals two new non-synonymous alleles in Amerindians and high CCR5*D32 frequency in Euro-Brazilians.
Boldt AB et al.
Genetics and Molecular Biology, 2009
Identification of the CCR5-Delta32 HIV resistance allele and new mutations of the CCR5 gene in different Tunisian populations.
Jlizi A et al.
Human Immunology, 2007
A novel 24-base pair deletion in the coding region of CCR5 in an African population.
Masquelier C et al.
Aids (london, England), 2007
Genetics of resistance to HIV infection: Role of co-receptors and co-receptor ligands.
Arenzana-Seisdedos F et al.
Seminars in Immunology, 2006
Inactivating mutations of G protein-coupled receptors and diseases: structure-function insights and therapeutic implications.
Tao YX
Pharmacology & Therapeutics, 2006
Variants of CCR5, which are permissive for HIV-1 infection, show distinct functional responses to CCL3, CCL4 and CCL5.
Dong HF et al.
Genes and Immunity, 2005
Are polymorphic markers within the alpha-1-antitrypsin gene associated with risk of human immunodeficiency virus disease?
Hayes VM et al.
The Journal of Infectious Diseases, 2003
African-based CCR5 single-nucleotide polymorphism associated with HIV-1 disease progression.
Hayes VM et al.
Aids (london, England), 2002
Novel mutations identified using a comprehensive CCR5-denaturing gradient gel electrophoresis assay.
Petersen DC et al.
Aids (london, England), 2001
Multiple nonfunctional alleles of CCR5 are frequent in various human populations.
Blanpain C et al.
Blood, 2000
Genetics of HIV-1 infection: chemokine receptor CCR5 polymorphism and its consequences.
Carrington M et al.
Human Molecular Genetics, 1999
Novel alleles of the chemokine-receptor gene CCR5.
Carrington M et al.
American Journal of Human Genetics, 1997
Association of the CCR5Δ32 Mutant Genotype with Sickle Cell Disease in Egyptian Patients.
El Sissy MH et al.
Hemoglobin, 0